Why Bacterial Vaginosis Keeps Coming Back: The Microbiome Truth Behind a Misunderstood Condition

Bacterial vaginosis affects nearly one in three women in the United States at some point in their lives. It is the most prevalent vaginal condition among women of reproductive age, more common than yeast infections, and yet it is frequently dismissed with a prescription and a brief conversation. For many women, that prescription works — at first. Then, weeks or months later, the familiar symptoms return: the unusual discharge, the distinctive odor, the subtle discomfort that signals something is off again.

If this pattern sounds familiar, you are not alone. Research suggests that up to 58 percent of women experience a recurrence of BV within 12 months of treatment. That statistic alone should prompt a different kind of conversation — one that goes beyond the prescription pad and into the underlying biology that makes this condition so stubbornly persistent.

What Bacterial Vaginosis Actually Is

Despite its name, BV is not a traditional infection in the way most people understand that term. It is more accurately described as a disruption of the vaginal microbiome — a shift in the delicate community of microorganisms that normally inhabit the vaginal environment.

A healthy vaginal microbiome is dominated by Lactobacillus species, bacteria that produce lactic acid and hydrogen peroxide to maintain a naturally acidic pH (typically between 3.8 and 4.5). This acidity creates an inhospitable environment for harmful pathogens. When BV occurs, Lactobacillus populations decline and are replaced by an overgrowth of anaerobic bacteria — organisms such as Gardnerella vaginalis, Prevotella species, and Mobiluncus — that thrive in a less acidic environment.

The result is a measurable shift in vaginal pH (generally above 4.5), an altered microbial community, and the hallmark symptoms that bring women into their clinician's office. What it is not, despite persistent cultural messaging, is a consequence of poor hygiene. BV is a physiological imbalance, not a cleanliness failure.

Why Antibiotics Alone Often Fall Short

The standard first-line treatment for BV in the United States is metronidazole, administered either orally or as a vaginal gel, or alternatively clindamycin. These antibiotics are effective at eliminating the anaerobic bacteria responsible for the imbalance — but therein lies a critical limitation.

Antibiotics do not selectively target only the problematic bacteria. They also reduce or eliminate the beneficial Lactobacillus colonies that are essential for long-term vaginal health. In other words, treatment addresses the overgrowth without restoring the protective ecosystem. Once the antibiotic course ends, the vaginal environment may still lack the Lactobacillus dominance needed to prevent recolonization by BV-associated bacteria.

This is why so many women experience relief followed by relapse. The infection is treated; the imbalance is not.

The Biofilm Problem No One Is Talking About

Emerging research has introduced another layer of complexity that helps explain why recurrent BV is so difficult to resolve. Studies have identified that Gardnerella vaginalis — often considered the primary driver of BV — is capable of forming dense biofilms on the vaginal epithelium.

Biofilms are structured communities of bacteria encased in a protective matrix, essentially a shield that makes them significantly more resistant to antibiotic penetration. Once a biofilm is established, standard antibiotic concentrations may eliminate surface bacteria while leaving the biofilm largely intact. When treatment concludes, bacteria within the biofilm can reseed the vaginal environment, triggering another episode.

This biofilm dynamic is not yet routinely addressed in standard clinical practice, which may be one of the most significant gaps between what the science currently shows and what women are actually receiving in treatment.

Vaginal pH: The Overlooked Metric

Vaginal pH is a straightforward, inexpensive, and clinically meaningful marker of vaginal health — and it is one that is frequently underutilized in routine care. Maintaining an acidic vaginal environment is not simply a byproduct of a healthy microbiome; it is an active defense mechanism.

Several factors can elevate vaginal pH and create conditions favorable to BV recurrence, including:

• Semen exposure, which is alkaline and can temporarily raise vaginal pH
• Hormonal fluctuations, particularly the decline in estrogen during perimenopause and menopause, which reduces Lactobacillus activity
• Menstrual blood, which is also alkaline
• Certain hygiene products, including scented soaps, douches, and some lubricants
• Antibiotic use for unrelated conditions, which can disrupt vaginal flora as a secondary effect

Understanding a patient's individual pH patterns — and the lifestyle and hormonal factors contributing to them — is an important part of building a sustainable, personalized approach to BV management.

What Comprehensive Care Looks Like

For women experiencing recurrent BV, a treatment strategy that extends beyond a single antibiotic prescription is both clinically justified and increasingly supported by research. A more comprehensive approach may include several elements working in concert.

Probiotic support targeting vaginal Lactobacillus restoration has shown meaningful promise in clinical studies. Specific strains — particularly Lactobacillus rhamnosus and Lactobacillus reuteri — have demonstrated the ability to colonize the vaginal environment and help restore protective acidity. Probiotic therapy is most effective when initiated in conjunction with, or immediately following, antibiotic treatment rather than as a standalone intervention.

Boric acid suppositories, while not a first-line treatment, are increasingly recognized as a valuable adjunctive therapy for recurrent BV. Boric acid works by lowering vaginal pH and disrupting biofilm formation, addressing two of the key mechanisms that drive recurrence. It is important to note that boric acid is for vaginal use only and should be used under clinical guidance.

Extended or suppressive antibiotic regimens — such as twice-weekly metronidazole gel used over a period of months — have been studied as a maintenance strategy for women with frequent recurrences. This approach requires individualized assessment, as the long-term impact on the broader vaginal microbiome must be carefully considered.

Hormonal evaluation is particularly relevant for women in perimenopause or postmenopause, as declining estrogen levels can significantly compromise the Lactobacillus-dominant environment that protects against BV. In some cases, localized vaginal estrogen therapy may be an appropriate component of a comprehensive plan.

Reframing BV as a Signal Worth Investigating

Beyond the immediate discomfort and disruption that BV causes, there are broader health implications that underscore why this condition deserves more than a cursory clinical response. Untreated or recurrent BV has been associated with an increased risk of acquiring sexually transmitted infections, including HIV and herpes simplex virus, as well as complications during pregnancy, including preterm birth.

These associations do not exist to alarm, but to contextualize. A vaginal microbiome in chronic imbalance is not a minor inconvenience. It is a signal from the body that something in the underlying environment — hormonal, immunological, microbial — is not functioning optimally.

At Femme Health & Med Spa, we approach recurrent BV with the seriousness it deserves. Rather than offering a single solution, we work to understand the full picture of each patient's vaginal health, hormonal status, lifestyle factors, and treatment history. Our goal is not simply to resolve the current episode, but to restore the conditions that allow the body to maintain its own protective balance.

A Conversation Worth Having

If you have been treated for BV more than once — or if you have noticed a pattern of recurring symptoms that never quite resolve — it is worth seeking care that goes deeper than the standard approach. You deserve a clinician who will ask about your history, consider your hormones, discuss your microbiome, and offer a treatment plan tailored to your specific physiology.

BV is not a reflection of how you care for yourself. It is a condition rooted in biology, and it responds best to care that honors that complexity. The conversation you deserve is available — and it begins with asking for more than a prescription.